Literature DB >> 26932552

Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Mary R Lee1, Matthew C H Rohn2, Gianluigi Tanda3, Lorenzo Leggio2,4.   

Abstract

The neuropeptide oxytocin plays a role in reward, stress, social affiliation, learning, and memory processes. As such, there is increasing interest in oxytocin as a potential treatment for addictions. The endogenous oxytocin system is itself altered by short- or long-term exposure to drugs of abuse. A large number of preclinical studies in rodents have investigated the effect of oxytocin administration on various drug-induced behaviors to determine whether oxytocin can reverse the neuroadaptations occurring with repeated drug and alcohol use. In addition, the mechanisms by which oxytocin acts to modify the behavioral response to drugs of abuse are beginning to be understood. More recently, a few small clinical studies have been conducted in cocaine, cannabis, and alcohol dependence. This review summarizes the preclinical as well as clinical literature to date on the oxytocin system and its relevance to drug and alcohol addiction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26932552      PMCID: PMC4815424          DOI: 10.1007/s40263-016-0313-z

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  105 in total

1.  Evoked axonal oxytocin release in the central amygdala attenuates fear response.

Authors:  H Sophie Knobloch; Alexandre Charlet; Lena C Hoffmann; Marina Eliava; Sergey Khrulev; Ali H Cetin; Pavel Osten; Martin K Schwarz; Peter H Seeburg; Ron Stoop; Valery Grinevich
Journal:  Neuron       Date:  2012-02-09       Impact factor: 17.173

2.  Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

Authors:  G J H Dumont; F C G J Sweep; R van der Steen; R Hermsen; A R T Donders; D J Touw; J M A van Gerven; J K Buitelaar; R J Verkes
Journal:  Soc Neurosci       Date:  2009       Impact factor: 2.083

3.  Oxytocin levels in social anxiety disorder.

Authors:  Elizabeth A Hoge; Mark H Pollack; Rebecca E Kaufman; Paul J Zak; Naomi M Simon
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 4.  Breaking the loop: oxytocin as a potential treatment for drug addiction.

Authors:  Iain S McGregor; Michael T Bowen
Journal:  Horm Behav       Date:  2011-12-14       Impact factor: 3.587

5.  Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference.

Authors:  Sarah J Baracz; Poppy I Rourke; Margery C Pardey; Glenn E Hunt; Iain S McGregor; Jennifer L Cornish
Journal:  Behav Brain Res       Date:  2011-12-06       Impact factor: 3.332

6.  Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice.

Authors:  Jia Qi; Jing-Yu Yang; Ming Song; Yan Li; Fang Wang; Chun-Fu Wu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

7.  Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement.

Authors:  Jia Qi; Jing-Yu Yang; Fang Wang; Ya-Nan Zhao; Ming Song; Chun-Fu Wu
Journal:  Neuropharmacology       Date:  2009-01-21       Impact factor: 5.250

8.  Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice.

Authors:  Masahide Yoshida; Yuki Takayanagi; Kiyoshi Inoue; Tadashi Kimura; Larry J Young; Tatsushi Onaka; Katsuhiko Nishimori
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

Review 9.  Oxytocin: the great facilitator of life.

Authors:  Heon-Jin Lee; Abbe H Macbeth; Jerome H Pagani; W Scott Young
Journal:  Prog Neurobiol       Date:  2009-04-10       Impact factor: 11.685

Review 10.  Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.

Authors:  Maurice Manning; Stoytcho Stoev; Bice Chini; Thierry Durroux; Bernard Mouillac; Gilles Guillon
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

View more
  41 in total

1.  Effect of oxytocin pretreatment on cannabis outcomes in a brief motivational intervention.

Authors:  Brian J Sherman; Nathaniel L Baker; Aimee L McRae-Clark
Journal:  Psychiatry Res       Date:  2017-01-20       Impact factor: 3.222

2.  Oxytocin Reduces Ethanol Self-Administration in Mice.

Authors:  Courtney E King; William C Griffin; Lauryn N Luderman; Malcolm M Kates; Jacqueline F McGinty; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-03-27       Impact factor: 3.455

3.  Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review.

Authors:  Marilyn Horta; Kathryn Kaylor; David Feifel; Natalie C Ebner
Journal:  Neurosci Biobehav Rev       Date:  2019-10-21       Impact factor: 8.989

Review 4.  Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics.

Authors:  Lee E Eiden; Ki Ann Goosens; Kenneth A Jacobson; Lorenzo Leggio; Limei Zhang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-18

5.  The effect of oxytocin, gender, and ovarian hormones on stress reactivity in individuals with cocaine use disorder.

Authors:  Brian J Sherman; Nathaniel L Baker; Kathleen T Brady; Jane E Joseph; Lisa M Nunn; Aimee McRae-Clark
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

6.  A Thalamo-Hypothalamic Pathway That Activates Oxytocin Neurons in Social Contexts in Female Rats.

Authors:  Melinda Cservenák; Dávid Keller; Viktor Kis; Emese A Fazekas; Hanna Öllös; András H Lékó; Éva R Szabó; Éva Renner; Ted B Usdin; Miklós Palkovits; Árpád Dobolyi
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

7.  Hepatic, lipid and genetic factors associated with obesity: crosstalk with alcohol dependence?

Authors:  Kimberly Goodyear; Mary R Lee; Melanie L Schwandt; Colin A Hodgkinson; Lorenzo Leggio
Journal:  World J Biol Psychiatry       Date:  2016-12-01       Impact factor: 4.132

8.  Oxytocin Reduces Alcohol Cue-Reactivity in Alcohol-Dependent Rats and Humans.

Authors:  Anita C Hansson; Anne Koopmann; Stefanie Uhrig; Sina Bühler; Esi Domi; Eva Kiessling; Roberto Ciccocioppo; Robert C Froemke; Valery Grinevich; Falk Kiefer; Wolfgang H Sommer; Sabine Vollstädt-Klein; Rainer Spanagel
Journal:  Neuropsychopharmacology       Date:  2017-11-01       Impact factor: 7.853

Review 9.  Influence of stress associated with chronic alcohol exposure on drinking.

Authors:  Howard C Becker
Journal:  Neuropharmacology       Date:  2017-04-19       Impact factor: 5.250

10.  Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay.

Authors:  M R Lee; K B Scheidweiler; X X Diao; F Akhlaghi; A Cummins; M A Huestis; L Leggio; B B Averbeck
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.